SLP Simulations Plus Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SLP

Price (delayed)

$18.35

Market cap

$371.13M

P/E Ratio

45.88

Dividend/share

N/A

EPS

$0.4

Enterprise value

$336.29M

?
Relative Growth: Rel. Growth: 56
Relative Strength: Rel. Strength: 78
Relative Valuation: Rel. Valuation: 49
Relative Profitability: Rel. Profitability: 85

With more than 25 years of experience serving clients globally, Simulations Plus stands as a premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug ...

Highlights
The company's EPS has surged by 113% QoQ and by 113% YoY
The net income has soared by 113% since the previous quarter and by 113% year-on-year
Sector: Healthcare
Industry: Health Information Services
Website: http://www.simulations-plus.com
Peers: SMSI

Key stats

What are the main financial stats of SLP

SLP stock price

How has the Simulations Plus stock price performed over time
Intraday
0.22%
1 week
0.16%
1 month
0.71%
1 year
29.23%
YTD
0.66%
QTD
0.22%

Financial performance

How have Simulations Plus's revenue and profit performed over time
Revenue
$82.06M
Gross profit
$52.01M
Operating income
$11.5M
Net income
$8.11M
Gross margin
63.4%
Net margin
9.9%
The operating margin has surged by 117% since the previous quarter and by 116% year-on-year
The operating income has surged by 117% since the previous quarter and by 116% year-on-year
The net income has soared by 113% since the previous quarter and by 113% year-on-year
The net margin has soared by 113% from the previous quarter and by 113% YoY

Price vs fundamentals

How does SLP's price correlate with its fundamentals

Growth

What is Simulations Plus's growth rate over time

Valuation

What is Simulations Plus stock price valuation
SLP P/E details
P/E
45.88
P/B
2.67
P/S
4.52
EV/EBIT
26.79
EV/EBITDA
18.51
EV/Sales
4.1
The company's EPS has surged by 113% QoQ and by 113% YoY
SLP's price to earnings (P/E) is 42% lower than its 5-year quarterly average of 79.5
The price to book (P/B) is 39% lower than the 5-year quarterly average of 4.4 but 16% higher than the last 4 quarters average of 2.3
SLP's equity is up by 12% year-on-year and by 3.9% since the previous quarter
The price to sales (P/S) is 63% less than the 5-year quarterly average of 12.3 but 19% more than the last 4 quarters average of 3.8
SLP's revenue is up by 2.1% YoY

Efficiency

How efficient is Simulations Plus business performance
The company's return on sales has surged by 119% QoQ and by 118% YoY
Simulations Plus's return on invested capital has surged by 118% QoQ and by 116% YoY
SLP's ROE has soared by 117% YoY and by 113% QoQ
The company's return on assets has surged by 116% YoY and by 113% QoQ

Dividends

What is SLP's dividend history
Dividend details
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Simulations Plus financials performed over time
The total liabilities is up by 32% year-on-year and by 10% since the previous quarter
The quick ratio has grown by 16% YoY
The debt is 100% less than the equity
The debt to equity has dropped by 100% year-on-year
The debt has contracted by 32% YoY and by 4.1% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.